Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 21 | 2016 | 102 | 3.440 |
Why?
|
| Perforant Pathway | 10 | 2016 | 15 | 2.790 |
Why?
|
| Hippocampus | 19 | 2016 | 561 | 1.700 |
Why?
|
| Dentate Gyrus | 7 | 2013 | 39 | 1.490 |
Why?
|
| Synapses | 11 | 2016 | 180 | 1.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 10 | 2013 | 137 | 0.790 |
Why?
|
| Long-Term Synaptic Depression | 3 | 2013 | 9 | 0.780 |
Why?
|
| Piperazines | 10 | 2013 | 111 | 0.740 |
Why?
|
| Neuronal Plasticity | 7 | 2007 | 103 | 0.720 |
Why?
|
| Electric Stimulation | 13 | 2016 | 184 | 0.710 |
Why?
|
| Rats | 25 | 2016 | 3483 | 0.620 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2016 | 1618 | 0.590 |
Why?
|
| Exploratory Behavior | 2 | 2007 | 75 | 0.560 |
Why?
|
| Excitatory Amino Acid Antagonists | 8 | 2016 | 99 | 0.550 |
Why?
|
| Wakefulness | 1 | 2016 | 21 | 0.540 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 137 | 0.480 |
Why?
|
| Environment | 2 | 2006 | 138 | 0.470 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2011 | 6 | 0.390 |
Why?
|
| Somatostatin | 5 | 2011 | 22 | 0.390 |
Why?
|
| Receptors, Opioid | 8 | 1997 | 51 | 0.390 |
Why?
|
| Opioid Peptides | 1 | 2011 | 28 | 0.390 |
Why?
|
| Memory | 3 | 2002 | 170 | 0.380 |
Why?
|
| Theta Rhythm | 2 | 2007 | 7 | 0.370 |
Why?
|
| Animals | 28 | 2016 | 15081 | 0.370 |
Why?
|
| Synaptic Transmission | 5 | 2005 | 146 | 0.340 |
Why?
|
| Afferent Pathways | 3 | 2007 | 37 | 0.320 |
Why?
|
| Nerve Fibers | 4 | 1997 | 34 | 0.290 |
Why?
|
| Male | 23 | 2016 | 20025 | 0.280 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2006 | 13 | 0.270 |
Why?
|
| Models, Neurological | 1 | 2007 | 128 | 0.270 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2016 | 79 | 0.250 |
Why?
|
| Computer Simulation | 1 | 2007 | 362 | 0.240 |
Why?
|
| Naltrexone | 2 | 2002 | 38 | 0.230 |
Why?
|
| Learning | 2 | 1996 | 117 | 0.210 |
Why?
|
| Electrodes, Implanted | 3 | 2016 | 16 | 0.210 |
Why?
|
| Enkephalins | 4 | 1996 | 33 | 0.190 |
Why?
|
| Receptors, Opioid, mu | 3 | 2002 | 55 | 0.190 |
Why?
|
| Narcotic Antagonists | 3 | 2011 | 57 | 0.160 |
Why?
|
| Rats, Inbred F344 | 4 | 2006 | 245 | 0.150 |
Why?
|
| Behavior, Animal | 3 | 2004 | 314 | 0.140 |
Why?
|
| Naloxone | 4 | 2011 | 52 | 0.140 |
Why?
|
| Neurons, Afferent | 1 | 1996 | 43 | 0.140 |
Why?
|
| Biophysics | 1 | 2016 | 37 | 0.140 |
Why?
|
| Dizocilpine Maleate | 1 | 2016 | 48 | 0.140 |
Why?
|
| Pyramidal Tracts | 1 | 1994 | 13 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2016 | 550 | 0.120 |
Why?
|
| Neural Pathways | 3 | 2004 | 124 | 0.120 |
Why?
|
| Nerve Growth Factors | 2 | 2004 | 33 | 0.110 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 3 | 1996 | 17 | 0.100 |
Why?
|
| Evoked Potentials | 5 | 1996 | 87 | 0.100 |
Why?
|
| Time Factors | 4 | 2004 | 1742 | 0.090 |
Why?
|
| Brain | 2 | 2004 | 1346 | 0.090 |
Why?
|
| Narcotics | 1 | 2008 | 32 | 0.080 |
Why?
|
| Neurons | 2 | 2006 | 1175 | 0.070 |
Why?
|
| Morphine | 1 | 2008 | 85 | 0.070 |
Why?
|
| Serotonin Agents | 1 | 2006 | 3 | 0.070 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2006 | 6 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 162 | 0.070 |
Why?
|
| Pyridines | 1 | 2006 | 116 | 0.060 |
Why?
|
| Body Temperature | 1 | 2004 | 36 | 0.060 |
Why?
|
| Autoradiography | 2 | 2004 | 36 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1039 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 109 | 0.060 |
Why?
|
| Receptors, Opioid, delta | 2 | 2002 | 23 | 0.060 |
Why?
|
| Food Deprivation | 1 | 2002 | 30 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2004 | 1207 | 0.050 |
Why?
|
| Maze Learning | 1 | 2002 | 105 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2003 | 513 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2000 | 89 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 623 | 0.040 |
Why?
|
| Cytokines | 1 | 2000 | 602 | 0.040 |
Why?
|
| Nerve Net | 1 | 1996 | 76 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 1015 | 0.030 |
Why?
|
| Microtubule Proteins | 2 | 2004 | 4 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 129 | 0.030 |
Why?
|
| Morphinans | 1 | 1992 | 1 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2004 | 305 | 0.020 |
Why?
|
| Indoles | 1 | 1992 | 158 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2004 | 517 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 36 | 0.020 |
Why?
|
| Pyramidal Cells | 2 | 2000 | 63 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2004 | 80 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 150 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 343 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 1549 | 0.010 |
Why?
|
| Growth Substances | 1 | 2000 | 14 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 12 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 626 | 0.010 |
Why?
|
| Humans | 2 | 1996 | 37093 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1997 | 51 | 0.010 |
Why?
|
| Anesthesia | 1 | 1994 | 14 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1994 | 136 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1994 | 20 | 0.010 |
Why?
|
| Endorphins | 1 | 1989 | 4 | 0.010 |
Why?
|
| Avoidance Learning | 1 | 1989 | 62 | 0.000 |
Why?
|
| Female | 1 | 2008 | 20969 | 0.000 |
Why?
|
| Chickens | 1 | 1989 | 133 | 0.000 |
Why?
|